Alteration of Deep Brain Stimulation Parameters for Dystonia

NCT ID: NCT00971854

Last Updated: 2009-10-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-09-30

Study Completion Date

2010-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Deep brain stimulation (DBS) involves placing electrodes into the brain. Through these electrodes, artificial electrical signals are chronically delivered into deep brain regions in order to alter abnormal brain activity. The artificial electrical signals are generated by a battery that is inserted under the skin of the chest. DBS is used to treat several disorders of movement, including dystonia. In dystonia, the electrodes are inserted into a brain region called the globus pallidus.

Globus pallidus stimulation can be very effective therapy for dystonia. However not all patients are equally responsive and therapeutic outcomes can be frustratingly variable. The reason for this variability is unclear. Such variability in response may need to be met by tailoring stimulation to individual patients.

Another issue with deep brain stimulation is battery life. Eventually, batteries become depleted and need to be replaced. Such battery replacements require an operation, hospital stay and the risk of introducing infection. The high electrical energy that has been used to treat dystonia means that batteries are typically replaced every year or two.

The artificial electrical signals of deep brain stimulation are delivered with three parameters; frequency (Hertz - Hz), voltage (volts) and pulse width (microseconds). It has recently been reported that lower frequency stimulation, at 60Hz rather than 130Hz, can be used effectively to treat dystonia. Such 60Hz stimulation may be more effective for some patients than others. The lower energy demands of 60Hz stimulation would also greatly improve battery life (potentially doubling battery life).

The aim of this study is to assess if 60Hz stimulation is more effective in ameliorating the dystonia of patients who have responded poorly to 130Hz pallidal stimulation. The current status of the evidence is one of clinical equipoise (uncertainty) and therefore suits a double blinded randomised trial.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dystonia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

60 Hz stimulation

Experimental reduced frequency pallidal stimulation

Group Type EXPERIMENTAL

Alteration of deep brain stimulator settings

Intervention Type PROCEDURE

From 130Hz to 60Hz pallidal stimulation

130 Hz stimulation

Current standard pallidal stimulation setting

Group Type NO_INTERVENTION

Alteration of deep brain stimulator settings

Intervention Type PROCEDURE

From 130Hz to 60Hz pallidal stimulation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Alteration of deep brain stimulator settings

From 130Hz to 60Hz pallidal stimulation

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Primary dystonia (focal cervical or generalised dystonia) who are receiving chronic (\>1 year) bilateral pallidal stimulation but have had poor therapeutic responses (\< 50% improvement in relevant dystonia severity rating scale\*) despite confirmation of accurate electrode position.
* Able to understand study requirements - able to provide consent.

* Relevant dystonia rating scales: Cervical dystonia - severity subsection of the Toronto Western Hospital spasmodic torticollis rating scale; Generalised dystonia - severity section of the Burke Fahn Marsden rating scale.

Exclusion Criteria

* None.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Oxford

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

University of Oxford

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tipu Aziz, Professor

Role: PRINCIPAL_INVESTIGATOR

University of Oxford, Nuffield Department of Surgery

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Oxford, Nuffield Department of Surgery

Oxford, Oxfordshire, United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Wesley Thevathasan, MBBS FRACP

Role: CONTACT

07748729186

Julian Woollard, MMBS BSc

Role: CONTACT

07779 654 944

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Wesley Thevathasan, MBBS FRACP

Role: primary

07748729186

Julian Woollard, MBBS BSc

Role: backup

07779 654 944

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R&D Study - 5898

Identifier Type: -

Identifier Source: secondary_id

09/H0603/11

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Deep Brain Stimulation Surgery for Focal Hand Dystonia
NCT02911103 ACTIVE_NOT_RECRUITING PHASE1/PHASE2